BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 34278663)

  • 1. Economic and health impacts of introducing Helicobacter pylori eradication strategy into national gastric cancer policy in Japan: A cost-effectiveness analysis.
    Kowada A; Asaka M
    Helicobacter; 2021 Oct; 26(5):e12837. PubMed ID: 34278663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Population-Based Helicobacter pylori Eradication Strategy Is More Cost-Effective than Endoscopic Screening.
    Kowada A
    Dig Dis Sci; 2023 May; 68(5):1735-1746. PubMed ID: 36565366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic and health impacts of Helicobacter pylori eradication strategy for the treatment of peptic ulcer disease: A cost-effectiveness analysis.
    Kowada A; Asaka M
    Helicobacter; 2022 Jun; 27(3):e12886. PubMed ID: 35343031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of Helicobacter pylori screening followed by eradication treatment for employees in Japan.
    Kowada A
    Epidemiol Infect; 2018 Oct; 146(14):1834-1840. PubMed ID: 30056808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of
    Kowada A
    Scand J Gastroenterol; 2019 Jun; 54(6):685-689. PubMed ID: 31190581
    [No Abstract]   [Full Text] [Related]  

  • 6. Endoscopy Is Cost-Effective for Gastric Cancer Screening After Successful Helicobacter pylori Eradication.
    Kowada A
    Dig Dis Sci; 2021 Dec; 66(12):4220-4226. PubMed ID: 33417196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-Effectiveness Analysis of Helicobacter pylori Eradication Therapy for Prevention of Gastric Cancer: A Markov Model.
    Han Y; Yan T; Ma H; Yao X; Lu C; Li Y; Li L
    Dig Dis Sci; 2020 Jun; 65(6):1679-1688. PubMed ID: 31673902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Both family-based Helicobacter pylori infection control and management strategy and screen-and-treat strategy are cost-effective for gastric cancer prevention.
    Ma J; Yu M; Shao QQ; Yu XC; Zhang C; Zhao JB; Yuan L; Qi YB; Hu RB; Wei PR; Xiao W; Chen Q; Jia BL; Chen CL; Lu H; Ding SZ
    Helicobacter; 2022 Aug; 27(4):e12911. PubMed ID: 35706404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness analysis of screen-and-treat strategy in asymptomatic Chinese for preventing Helicobacter pylori-associated diseases.
    Chen Q; Liang X; Long X; Yu L; Liu W; Lu H
    Helicobacter; 2019 Apr; 24(2):e12563. PubMed ID: 30672082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect on Helicobacter pylori eradication therapy against gastric cancer in Japan.
    Tsuda M; Asaka M; Kato M; Matsushima R; Fujimori K; Akino K; Kikuchi S; Lin Y; Sakamoto N
    Helicobacter; 2017 Oct; 22(5):. PubMed ID: 28771894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategy for eliminating gastric cancer in Japan.
    Asaka M; Kato M; Graham DY
    Helicobacter; 2010 Dec; 15(6):486-90. PubMed ID: 21073603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Family-based Helicobacter pylori infection control and management strategy and screen-and-treat strategy are highly cost-effective in preventing multiple upper gastrointestinal diseases in Chinese population at national level.
    Zhang C; Qi YB; Hu RB; Xu L; Li XT; Ma J; Shao QQ; Abdun MA; Ur Rahman I; Shi WJ; Li FQ; Yu JJ; Yuan MK; Chen Q; Lu H; Ding SZ
    Helicobacter; 2024; 29(3):e13063. PubMed ID: 38874128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials.
    Parsonnet J; Harris RA; Hack HM; Owens DK
    Lancet; 1996 Jul; 348(9021):150-4. PubMed ID: 8684154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A screening program to test and treat for Helicobacter pylori infection: Cost-utility analysis by age, sex and ethnicity.
    Teng AM; Kvizhinadze G; Nair N; McLeod M; Wilson N; Blakely T
    BMC Infect Dis; 2017 Feb; 17(1):156. PubMed ID: 28219322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening and eradication of
    Liou JM; Malfertheiner P; Lee YC; Sheu BS; Sugano K; Cheng HC; Yeoh KG; Hsu PI; Goh KL; Mahachai V; Gotoda T; Chang WL; Chen MJ; Chiang TH; Chen CC; Wu CY; Leow AH; Wu JY; Wu DC; Hong TC; Lu H; Yamaoka Y; Megraud F; Chan FKL; Sung JJ; Lin JT; Graham DY; Wu MS; El-Omar EM;
    Gut; 2020 Dec; 69(12):2093-2112. PubMed ID: 33004546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori test-and-treat program can be cost-effective to prevent gastric cancer in Taiwanese adults: referred to the nationwide reimbursement database.
    Cheng HC; Wang JD; Chen WY; Chen CW; Chang SC; Sheu BS
    Helicobacter; 2015 Apr; 20(2):114-24. PubMed ID: 25382169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Helicobacter pylori eradication on gastric cancer incidence in the Japanese population: a systematic evidence review.
    Lin Y; Kawai S; Sasakabe T; Nagata C; Naito M; Tanaka K; Sugawara Y; Mizoue T; Sawada N; Matsuo K; Kitamura T; Utada M; Ito H; Shimazu T; Kikuchi S; Inoue M;
    Jpn J Clin Oncol; 2021 Jul; 51(7):1158-1170. PubMed ID: 33893508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Strategies for extermination of gastric cancer from Japan].
    Asaka M
    Nihon Rinsho; 2011 Jan; 69(1):173-82. PubMed ID: 21226280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicobacter pylori Eradication to Eliminate Gastric Cancer: The Japanese Strategy.
    Asaka M; Mabe K; Matsushima R; Tsuda M
    Gastroenterol Clin North Am; 2015 Sep; 44(3):639-48. PubMed ID: 26314673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of eradication of Helicobacter pylori on gastric cancer prevention in healthy asymptomatic populations.
    Bae SE; Choi KD; Choe J; Kim SO; Na HK; Choi JY; Ahn JY; Jung KW; Lee J; Kim DH; Chang HS; Song HJ; Lee GH; Jung HY
    Helicobacter; 2018 Apr; 23(2):e12464. PubMed ID: 29345408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.